Radioactive drug shows promise against advanced cancers
NCT ID NCT03872778
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new radioactive drug, 177Lu-NeoB, in 35 adults with advanced solid tumors that have a specific marker (GRPR). The goal was to check safety, find the best dose, and see if it shrinks tumors. It is an early-stage trial, so it focuses on safety and dosing, not a cure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEOPLASMS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Addenbroke's hospital
Cambridge, United Kingdom
-
CHU de Grenoble
La Tronche, France
-
City of Hope
Duarte, California, 91010, United States
-
Erasmus MC
Rotterdam, Netherlands
-
John Hopkins University
Baltimore, Maryland, 21287, United States
-
MD Anderson Cancer Center
Houston, Texas, 77030, United States
-
Medical University of Innsbruck
Innsbruck, Austria
-
Oregon Health & Science University
Portland, Oregon, 97239, United States
-
Pittsburgh University
Pittsburgh, Pennsylvania, 15213, United States
-
Stanford University
Stanford, California, 94305, United States
-
Vall d'Hebron Institute of Oncology
Barcelona, Spain